Which patient population would most benefit from inhaled insulin (Afrezza)?
Community PollStarted
Which patient population would most benefit from inhaled insulin (Afrezza)?
25 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Endocrinology · Texas Diabetes And Endocrinology Pa
Answered on
Afrezza has the fastest onset of action and peak and shortest duration of action of any of the “ultra-rapid” prandial insulins. Its peak effect is 45 minutes vs 2 hours for the fastest injected insulin. Its duration of action is 2-3 hours vs 5-8 hours for injected mealtime insulins. A recent study s...
Join for free or sign in to see the full answer